We would love to hear your thoughts about our site and services, please take our survey here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBluefield Solar Regulatory News (BSIF)

Share Price Information for Bluefield Solar (BSIF)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 104.00
Bid: 103.20
Ask: 104.00
Change: 1.60 (1.56%)
Spread: 0.80 (0.775%)
Open: 103.60
High: 104.00
Low: 103.20
Prev. Close: 102.40
BSIF Live PriceLast checked at -
Bluefield Solar Income Fund is an Investment Trust

To provide Shareholders with an attractive return, principally in the form of quarterly income distributions by being invested primarily in solar energy assets located in the UK.

Find out More

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Result of AGM

28 Nov 2023 15:55

RNS Number : 9532U
Bluefield Solar Income Fund Limited
28 November 2023

28 November 2023

Bluefield Solar Income Fund Limited

('Bluefield Solar' or the 'Company')

Result of Annual General Meeting

Bluefield Solar (LON: BSIF), the London listed UK income fund focused primarily on acquiring and managing solar energy assets, announces that at the Annual General Meeting ("AGM") of the Company held at 10.00 am on 28 November 2023, Ordinary Resolutions 1 to 12 and Special Resolutions 14 and 15 were passed without amendment. Ordinary Resolution 13 did not pass.

The voting breakdown of all resolutions follow:

Resolution

Votes For**

Votes Against

Votes Withheld*

1 - Ordinary

337,555,008

99.99%

38,590

0.01%

12,013

2 - Ordinary

319,616,841

94.72%

17,819,263

5.28%

169,507

3 - Ordinary

334,145,478

98.99%

3,404,454

1.01%

55,679

4 - Ordinary

330,128,407

98.97%

3,445,731

1.03%

4,031,473

5 - Ordinary

292,343,939

86.64%

45,069,084

13.36%

192,588

6 - Ordinary

334,148,826

99.00%

3,391,926

1.00%

64,859

7 - Ordinary

315,265,337

93.40%

22,276,819

6.60%

63,455

8 - Ordinary

315,454,750

94.65%

17,839,621

5.35%

4,311,240

9 - Ordinary

337,499,502

99.98%

65,399

0.02%

40,710

10 - Ordinary

337,583,645

100.00%

9,953

0.00%

12,013

11 - Ordinary

334,977,404

99.23%

2,612,874

0.77%

13,833

12 - Ordinary

332,798,910

98.58%

4,782,510

1.42%

22,691

13 - Ordinary

140,900,541

41.74%

196,644,593

58.26%

58,977

14 - Special

331,944,511

98.35%

5,579,893

1.65%

79,707

15 - Special

330,810,329

98.01%

6,708,580

1.99%

85,202

*A vote withheld is not a vote in law and is therefore not counted towards the proportion of votes "for" or "against" the Resolution.

** including discretionary votes.

The Company notes that the quantum and duration of the authority to allot an unlimited number of shares sought under Resolution 13 is outside of acceptable norms for shareholders, and noting the significant number of votes received against it, commits to seeking an appropriate level of authority at the next AGM.

The full text of the Special Resolutions is noted below:

Resolution 14

That, in substitution for any existing disapplication authority in force as at the date of this Annual General Meeting, the Directors be and are hereby generally and unconditionally authorised to allot, issue and/or sell equity securities for cash as if article 6.2 of the Articles of Incorporation did not apply to any such allotment, issue and/or sale, provided that this power shall be limited to the allotment, issue and/or sale of up to 10 per cent. of the Ordinary Shares in issue as at the date of this Annual General Meeting for the period expiring at the date falling 15 months after the date of the passing of this resolution or the conclusion of the next annual general meeting of the Company, whichever is earlier (unless previously renewed, varied or revoked by the Company in a general meeting), save that the Company shall be entitled to make offers or agreements before the expiry of such power which would or might require equity securities to be allotted and issued after such expiry and the Directors shall be entitled to allot and issue equity securities pursuant to any such offer or agreement as if the power conferred hereby had not expired.

Resolution 15

That, in addition to any existing authorities granted to the Directors, the Directors be, and hereby are, empowered to allot, issue and/or sell equity securities for cash as if article 6.2 of the Articles of Incorporation did not apply to any such allotment, issue and/or sale, provided that this power shall be limited to the allotment, issue and/or sale of up to an additional 10 per cent. of the Ordinary Shares in issue as at the date of this Annual General Meeting for the period expiring at the date falling 15 months after the date of the passing of this resolution or the conclusion of the next annual general meeting of the Company, whichever is earlier (unless previously renewed, varied or revoked by the Company in general meeting), save that the Company shall be entitled to make offers or agreements before the expiry of such power which would or might require equity securities to be allotted and issued after such expiry and the Directors shall be entitled to allot and issue equity securities pursuant to any such offer or agreement as if the power conferred hereby had not expired.

For further information:

Bluefield Partners LLP (Company Investment Adviser)James Armstrong / Neil Wood / Giovanni Terranova

Tel: +44 (0) 20 7078 0020 www.bluefieldllp.com

Deutsche Numis (Company Broker)Tod Davis / David Benda / Matt Goss

Tel: +44 (0) 20 7260 1000 www.dbnumis.com

Ocorian Administration (Guernsey) Limited (Company Secretary & Administrator) Chezi Hanford

Tel: +44 (0) 1481 742 742 www.ocorian.com

Media enquiries: Buchanan (PR Adviser)Henry Harrison-Topham / Henry Wilson

Tel: +44 (0) 20 7466 5000 www.buchanan.uk.comBSIF@buchanan.uk.com

About Bluefield Solar

Bluefield Solar is a London listed income fund focused primarily on acquiring and managing solar energy assets. Not less than 75% of the Company's gross assets will be invested into UK solar assets. The Company can also invest up to 25% of its gross assets into other technologies, such as wind and storage. Bluefield Solar owns and operates a UK portfolio of 812MW, comprising 754MW of solar and 58MW of onshore wind.

Further information can be viewed at www.bluefieldsif.com

About Bluefield Partners

Bluefield Partners LLP was established in 2009 and is an investment adviser to companies and funds investing in renewable energy infrastructure. It has a proven record in the selection, acquisition and supervision of large-scale energy assets in the UK and Europe. The team has been involved in over £6.5 billion renewable funds and/or transactions in both the UK and Europe, including over £1 billion in the UK since December 2011.

Bluefield Partners LLP has led the acquisitions of, and currently advises on, over 100 UK based solar PV assets that are agriculturally, commercially or industrially situated. Based in its London office, it is supported by a dedicated and experienced team of investment, legal and portfolio executives. Bluefield Partners LLP was appointed Investment Adviser to Bluefield Solar in June 2013.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
END
RAGFEDFIAEDSEIF
Date   Source Headline
26th Apr 20247:00 amRNSTransaction in Own Shares
25th Apr 20248:39 amRNSUpdate from QuotedData
25th Apr 20247:00 amRNSTransaction in Own Shares
24th Apr 20247:00 amRNSTransaction in Own Shares
23rd Apr 20247:00 amRNSTransaction in Own Shares
22nd Apr 20247:00 amRNSTransaction in Own Shares
19th Apr 20247:00 amRNSTransaction in Own Shares
18th Apr 20242:32 pmRNSDirector/PDMR Shareholding
18th Apr 20247:00 amRNSTransaction in Own Shares
17th Apr 20247:00 amRNSTransaction in Own Shares
16th Apr 20247:00 amRNSTransaction in Own Shares
15th Apr 20247:00 amRNSTransaction in Own Shares
12th Apr 20247:00 amRNSTransaction in Own Shares
11th Apr 202411:54 amRNSDirector/PDMR Shareholding
10th Apr 20247:00 amRNSTransaction in Own Shares
9th Apr 20243:25 pmRNSDirector/PDMR Shareholding
9th Apr 20247:00 amRNSTransaction in Own Shares
8th Apr 20247:00 amRNSTransaction in Own Shares
5th Apr 20247:00 amRNSTransaction in Own Shares
4th Apr 20247:00 amRNSTransaction in Own Shares
3rd Apr 202410:57 amRNSTransaction in Own Shares - Correction
3rd Apr 20247:00 amRNSTransaction in Own Shares
2nd Apr 20247:01 amRNSTotal Voting Rights
2nd Apr 20247:00 amRNSTransaction in Own Shares
28th Mar 20247:00 amRNSTransaction in Own Shares
27th Mar 20243:37 pmRNSDirector/PDMR Shareholding
27th Mar 20247:00 amRNSTransaction in Own Shares
26th Mar 20243:12 pmRNSDirector/PDMR Shareholding
26th Mar 20247:00 amRNSTransaction in Own Shares
25th Mar 20245:31 pmRNSDirector/PDMR Shareholding
25th Mar 20244:21 pmRNSDirector/PDMR Shareholding
25th Mar 20247:00 amRNSTransaction in Own Shares
22nd Mar 20247:00 amRNSTransaction in Own Shares
21st Mar 20247:00 amRNSTransaction in Own Shares
20th Mar 20247:00 amRNSTransaction in Own Shares
19th Mar 20247:00 amRNSTransaction in Own Shares
18th Mar 20247:00 amRNSTransaction in Own Shares
15th Mar 20243:57 pmRNSDirector/PDMR Shareholding
15th Mar 20241:52 pmRNSDirector/PDMR Shareholding
15th Mar 20247:00 amRNSTransaction in Own Shares
14th Mar 20247:00 amRNSTransaction in Own Shares
13th Mar 20247:00 amRNSTransaction in Own Shares
12th Mar 20247:00 amRNSTransaction in Own Shares
11th Mar 20247:00 amRNSTransaction in Own Shares
8th Mar 20247:00 amRNSTransaction in Own Shares
7th Mar 20247:00 amRNSTransaction in Own Shares
6th Mar 20247:00 amRNSTransaction in Own Shares
5th Mar 20247:00 amRNSTransaction in Own Shares
1st Mar 20243:02 pmRNSDirector/PDMR Shareholding
28th Feb 20243:07 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.